Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan

OBJECTIVES: To determine prognostic factors of clinically relevant radiographic progression (CRRP) in patients with rheumatoid arthritis (RA) achieving remission or low disease activity (LDA) in clinical practice. METHODS: Using data from a nationwide, multicenter, prospective study in Japan, we eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Tomohiro, Okada, Akitomo, Fukuda, Takaaki, Hidaka, Toshihiko, Ishii, Tomonori, Ueki, Yukitaka, Kodera, Takao, Nakashima, Munetoshi, Takahashi, Yuichi, Honda, Seiyo, Horai, Yoshiro, Watanabe, Ryu, Okuno, Hiroshi, Aramaki, Toshiyuki, Izumiyama, Tomomasa, Takai, Osamu, Miyashita, Taiichiro, Sato, Shuntaro, Kawashiri, Shin-ya, Iwamoto, Naoki, Ichinose, Kunihiro, Tamai, Mami, Origuchi, Tomoki, Nakamura, Hideki, Aoyagi, Kiyoshi, Eguchi, Katsumi, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432072/
https://www.ncbi.nlm.nih.gov/pubmed/28505163
http://dx.doi.org/10.1371/journal.pone.0175281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432072/
https://www.ncbi.nlm.nih.gov/pubmed/28505163
http://dx.doi.org/10.1371/journal.pone.0175281

Ejemplares similares